Top Markets
#1 Cortex Cortex +174.22%
#2 GEKKO GEKKO +44.25%
#3 ADO Protocol ADO Protocol +18.41%
#4 o1.exchange o1.exchange +10.98%
#5 Official Trump Official Trump +10.62%
#6 aelf aelf +10.25%
#7 DAPPOS DAPPOS +9.52%
#8 Bless Bless +8.43%
#9 Status Status +7.95%
#10 Seeker Seeker +7.66%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

688076
Rank in Stocks #8443
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company,... Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Share Price
$3.99
Last synced: 2026-08-28
Market Cap
$1.26B
Change (1 day)
-0.04%
Change (1 year)
-33.48%
Country
CN
Trade Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)

Category

Healthcare
EPS for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)
EPS as of 2026 TTM: 0
According to Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH